Table 2.
Compound | MOR |
KOR |
DOR |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EC50 (nM) | pEC50 ± SEM | Emax (% DAMGO) | Log (Emax/EC50) | ΔLog (Emax/EC50) | MOR vs. KOR ΔΔLog (Emax/EC50) | MOR vs. KOR Selectivity | MOR vs. DOR ΔΔLog (Emax/EC50) | MOR vs. DOR Selectivity | EC50 (nM) | pEC50 ± SEM | Emax (% Sal A) | Log (Emax/EC50) | ΔLog (Emax/EC50) | EC50 (nM) | pEC50 ± SEM | Emax (% DADLE) | Log (Emax/EC50) | ΔLog (Emax/EC50) | |
Isotonitazene | 0.033 | 10.48 ± 0.04 | 105.0 ± 1.1 ∗ | 10.49 | 1.85 | 4.96 | >10,000 | 4.97 | >10,000 | 335 | 6.48 ± 0.09 | 85.9 ± 4.1 | 6.41 | −3.11 | 245 | 6.61 ± 0.07 | 89.9 ± 3.4 | 6.56 | −3.13 |
Metonitazene | 0.34 | 9.46 ± 0.06 | 104.9 ± 1.9 | 9.46 | 0.82 | 2.89 | 775 | 4.14 | >10,000 | 25.9 | 7.59 ± 0.11 | 73.1 ± 3.3 | 7.45 | −2.07 | 221 | 6.65 ± 0.16 | 51.9 ± 4.2 | 6.37 | −3.32 |
N-desethyl isotonitazene | 0.14 | 9.85 ± 0.06 | 115.7 ± 1.2 ∗ | 9.88 | 1.24 | 5.04 | >10,000 | 4.22 | >10,000 | 1060 | 5.98 ± 0.22 | 55.8 ± 8.3 | 5.72 | −3.80 | 153 | 6.81 ± 0.18 | 77.1 ± 6.7 | 6.7 | −2.99 |
Fentanyl | 3.28 | 8.48 ± 0.06 | 104.1 ± 1.9 | 8.49 | −0.16 | 1.74 | 55 | 3.27 | 1,850 | 19.7 | 7.70 ± 0.05 | 84.4 ± 3.6 | 7.63 | −1.89 | 466 | 6.33 ± 0.08 | 86.2 ± 3.9 | 6.27 | −3.42 |
Morphine | 7.43 | 8.13 ± 0.06 | 86.1 ± 2.1 ∗ | 8.08 | −0.56 | 2.33 | 215 | 2.48 | 302 | 207 | 6.68 ± 0.08 | 88.3 ± 1.7 | 6.63 | −2.89 | 186 | 6.73 ± 0.06 | 82.9 ± 2.7 | 6.65 | −3.04 |
All receptors are human receptors, and expressed in HEKT cells. All data represent mean and standard error of the mean (S.E.M) from at least three independent experiments performed in triplicate, and are represented as mean ± SEM. The pEC50 values for DAMGO, salvinorin A, and DADLE at their cognate receptors are 8.65 ± 0.04, 9.52 ± 0.04, 9.69 ± 0.06, respectively. Emax values at MOR marked with ∗ are statistically significantly different from that of DAMGO as determined by the extra sum-of-squares F test, with p < 0.0001.